https://orcid.org/0000-0002-2899-3919
References
- Hoshina T, Aonuma H, Ote M, et al. Intensive diagnostic management of coronavirus disease 2019 (COVID-19) in academic settings in Japan: challenge and future. Inflamm Regen. 2020;40(1):38. doi:10.1186/s41232-020-00147-2
- Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). OurWorldInData.org. 2020. Accessed July 12, 2023. https://ourworldindata.org/coronavirus.
- Schneider EC. Failing the Test — the Tragic Data Gap Undermining the U.S. Pandemic Response. N Engl J Med. 2020;383(4):299–302. doi:10.1056/NEJMp2014836
- Mascuch SJ, Fakhretaha-Aval S, Bowman JC, et al. A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits. J Biol Chem. 2020;295(46):15438–15453. doi:10.1074/jbc.RA120.015434
- Velu P, Craney A, Ruggiero P, et al. Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution. J Mol Diagn. 2021;23(2):149–158. doi:10.1016/j.jmoldx.2020.10.019
- Sparks R, Balgahom R, Janto C, Polkinghorne A, Branley J, Samarasekara H. An Australian diagnostic microbiology surge response to the COVID-19 pandemic. Diagn Microbiol Infect Dis. 2021;100(1):115309. doi:10.1016/j.diagmicrobio.2021.115309
- Landaverde L, McIntyre D, Robson J, et al. Buildout and integration of an automated high-throughput CLIA laboratory for SARS-CoV-2 testing on a large urban campus. SLAS Technol. 2022;27(5):302–311. doi:10.1016/j.slast.2022.06.003
- Aitken J, Ambrose K, Barrell S, et al. Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020;38(8):927–931. doi:10.1038/s41587-020-0588-y
- Act on Clinical Laboratory Technicians, Act No. 76, Article 20-3. 1958. Accessed December 1, 2023. https://www.japaneselawtranslation.go.jp/en/laws/view/2956#je_ch5at1.
- Kitahara K, Nishikawa Y, Yokoyama H, Kikuchi Y, Sakoi M. An overview of the reclassification of COVID-19 of the Infectious Diseases Control Law in Japan. Glob Health Med. 2023;5(2):70–74. doi:10.35772/ghm.2023.01023
- Quacquarelli Symonds QS. QS World University Rankings by Subject 2023: medicine. Available from: https://www.topuniversities.com/university-subject-rankings/medicine. Accessed December 12, 2023.
- INCOSE. INCOSE Systems Engineering Handbook: A Guide for System Life Cycle Processes and Activities. 4th. Walden DD, Roedler GJ, Forsberg KJ, Hamelin RD, Shortell TM, eds. John Wiley and Sons. 2015. Available from: https://www.wiley.com/en-us/INCOSE+Systems+Engineering+Handbook%3A+A+Guide+for+System+Life+Cycle+Processes+and+Activities%2C+4th+Edition-p-9781118999400. Accessed November 24, 2022.
- Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157–160. doi:10.23750/abm.v91i1.9397
- Watanabe T, Yabu T. Japan’s voluntary lockdown. PLoS One. 2021;16(6):e0252468. doi:10.1371/journal.pone.0252468
- Prime Minister’s Office of Japan. [COVID-19] Declaration of a State of Emergency in response to the Novel Coronavirus Disease; 2020. Available from: https://japan.kantei.go.jp/ongoingtopics/_00018.html. Accessed December 11, 2023.
- World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19; 2020. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-The-media-briefing-on-covid-19---11-march-2020. Accessed December 11, 2023.
- Object Management Group. Unified Architecture Framework (UAF) 1.0.; 2017. Available from: https://www.omg.org/spec/UAF/1.0. Accessed November 24, 2022.
- Harada S, Uno S, Ando T, et al. Control of a Nosocomial Outbreak of COVID-19 in a University Hospital. Open Forum Infect Dis. 2020;7(12):ofaa512. doi:10.1093/ofid/ofaa512
- Uchida S, Uwamino Y, Uno S, et al. Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan. J Clin Virol. 2021;142:104915. doi:10.1016/j.jcv.2021.104915
- Oba J, Taniguchi H, Sato M, et al. RT-PCR Screening Tests for SARS-CoV-2 with Saliva Samples in AsymptomaticPeople: strategy to Maintain Social and Economic Activities while Reducing the Risk ofSpreading the Virus. Keio J Med. 2021;70(2):35–43. doi:10.2302/kjm.2021-0003-OA
- Hause M, Bleakley G, Morkevicius A. TECHNOLOGY UPDATE ON THE UNIFIED ARCHITECTURE FRAMEWORK (UAF). INSIGHT. 2017;20(2):71–78. doi:10.1002/inst.12153
- Head of Health Policy Bureau M of HL and WJ. Handling of the Temporary Establishment of External Clinical Laboratory for Conducting Nucleic Acid Tests Only for Novel Coronavirus Infection. Health Policy Publication No 0305 (1); 2020.
- Osawa E, Okuda H, Koto-Shimada K, Shibanuma A, Saito T. The Environment Encouraging COVID-19 Response at Public Health Centers and Future Challenges in Japan. Int J Environ Res Public Health. 2022;19(6):3343. doi:10.3390/ijerph19063343
- Machida M, Wada K. Public health responses to COVID-19 in Japan. Glob Health Med. 2022;4(2):78–82. doi:10.35772/ghm.2022.01025
- Woloshin S, Patel N, Kesselheim AS. False Negative Tests for SARS-CoV-2 Infection — challenges and Implications. N Engl J Med. 2020;383(6):e38. doi:10.1056/NEJMp2015897